Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 3/20 | 0.36 |
| ▸ | TDO2 | P48775 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13139322 | 0.86 | ACHE (0.33) | AOC3 | |
| SCHEMBL1727192 | 0.81 | GABRA1 (0.31) | — | |
| SCHEMBL3743698 | 0.77 | AOC3 (0.53) | IDO1TDO2CES2CES1AOC3 | |
| SCHEMBL6204939 | 0.75 | CES2 (0.42) | IDO1TDO2CES2CES1AOC3 | |
| SCHEMBL6204937 | 0.75 | CES2 (0.38) | IDO1TDO2CES2CES1AOC3 | |
| SCHEMBL6205426 | 0.74 | AOC3 (0.47) | IDO1TDO2AOC3 | |
| Methoxymethane SCHEMBL27837378 | 0.73 | CA12 (0.47) | IDO1CES2CES1CA12CA1 | |
| SCHEMBL9324044 | 0.70 | ALDH1A1 (0.36) | AOC3 | |
| SCHEMBL16105655 | 0.69 | CES2 (0.39) | IDO1TDO2CES2CES1CA12 | |
| SCHEMBL2343056 | 0.69 | KDM4E (0.43) | IDO1TDO2CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1506175-A1 | N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2005-02-16 | — | — | EP | disclosed |
| WO-2003097609-A1 | N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2003-11-27 | — | — | WO | disclosed |